Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Right on the heels of a PhIII failure, Merck neuroscience doubles down with a new drug targeting tau
Right on the heels of a PhIII failure, Merck neuroscience doubles down with a new drug targeting tau
Right on the heels of a PhIII failure, Merck neuroscience doubles down with a new drug targeting tau
Submitted by
admin
on May 25, 2017 - 9:14am
Source:
Endpoints
News Tags:
Merck
Neuroscience
anti-tau antibodies
R&D
drug development
Headline:
Right on the heels of a PhIII failure, Merck neuroscience doubles down with a new drug targeting tau
Do Not Allow Advertisers to Use My Personal information
